Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Heinz Grunze, Eduard Vieta, Guy M. Goodwin, Charles Bowden, Rasmus W. Licht, Jean-Michel Azorin, Lakshmi Yatham, Sergey Mosolov, Hans-Jürgen Möller & Siegfried Kasper. (2018) The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder. The World Journal of Biological Psychiatry 19:1, pages 2-58.
Read now
Read now
Ricardo P. Garay, Carlos A. Zarate$suffix/text()$suffix/text(), Thomas Charpeaud, Leslie Citrome, Christoph U. Correll, Ahcène Hameg & Pierre-Michel Llorca. (2017) Investigational drugs in recent clinical trials for treatment-resistant depression. Expert Review of Neurotherapeutics 17:6, pages 593-609.
Read now
Read now
Christoffer Polcwiartek, Kristian Kragholm, Ole Schjerning, Claus Graff & Jimmi Nielsen. (2016) Cardiovascular safety of antipsychotics: a clinical overview. Expert Opinion on Drug Safety 15:5, pages 679-688.
Read now
Read now
Leslie Citrome. (2013)
Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability. Expert Opinion on Drug Metabolism & Toxicology 9:2, pages 193-206.
Read now
Read now
Leslie Citrome & Henry A Nasrallah. (2012) On-label on the table: what the package insert informs us about the tolerability profile of oral atypical antipsychotics, and what it does not. Expert Opinion on Pharmacotherapy 13:11, pages 1599-1613.
Read now
Read now
Jimmi Nielsen. (2011) The safety of atypical antipsychotics: does QTc provide all the answers?. Expert Opinion on Drug Safety 10:3, pages 341-344.
Read now
Read now
Articles from other publishers (16)
Leslie Citrome & Jan Volavka. (2021) Specific Anti-hostility Effects of Atypical Antipsychotics in Persons with Schizophrenia: From Clozapine to Cariprazine. Harvard Review of Psychiatry 29:1, pages 20-34.
Crossref
Crossref
Annamaria Mascolo, Cristina Scavone, Concetta Rafaniello & A. Capuano. 2020. Brain and Heart Dynamics. Brain and Heart Dynamics
721
729
.
A. Mascolo, C. Scavone, C. Rafaniello & A. Capuano. 2019. Brain and Heart Dynamics. Brain and Heart Dynamics
1
10
.
Diogo Ramalho & João Freitas. (2018) Drug-induced life-threatening arrhythmias and sudden cardiac death: A clinical perspective of long QT, short QT and Brugada syndromes. Revista Portuguesa de Cardiologia (English Edition) 37:5, pages 435-446.
Crossref
Crossref
Diogo Ramalho & João Freitas. (2018) Drug-induced life-threatening arrhythmias and sudden cardiac death: A clinical perspective of long QT, short QT and Brugada syndromes. Revista Portuguesa de Cardiologia 37:5, pages 435-446.
Crossref
Crossref
Oytun Erbas & Mustafa Yilmaz. (2013) Metoprolol and diltiazem ameliorate ziprasidone-induced prolonged corrected QT interval in rats. Toxicology and Industrial Health 31:12, pages 1152-1157.
Crossref
Crossref
J. Peuskens, L. Pani, J. Detraux & M. De Hert. (2014) The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: A Comprehensive Review. CNS Drugs.
Crossref
Crossref
Leslie Citrome. (2013) A Review of the Pharmacology, Efficacy and Tolerability of Recently Approved and Upcoming Oral Antipsychotics: An Evidence-Based Medicine Approach. CNS Drugs 27:11, pages 879-911.
Crossref
Crossref
Ya-Mei Bai, Ching-Jui Chang, Shang-Ying Tsai, Yi-Chyan Chen, Mei-Chun Hsiao, Cheng-Ta Li, Peichi Tu, Shang-Wen Chang, Winston W. Shen & Tung-Ping Su. (2013) Taiwan consensus of pharmacological treatment for bipolar disorder. Journal of the Chinese Medical Association 76:10, pages 547-556.
Crossref
Crossref
Donald C. Goff, Joseph P. McEvoy, Leslie Citrome, Arnold W. Mech, Juan R. Bustillo, Roberto Gil, Peter Buckley, Theo C. Manschreck, Eric D. Achtyes & Eric A. Macklin. (2013) High-Dose Oral Ziprasidone Versus Conventional Dosing in Schizophrenia Patients With Residual Symptoms. Journal of Clinical Psychopharmacology 33:4, pages 485-490.
Crossref
Crossref
David M Gardner, Andrea L Murphy, Stan Kutcher, Serge Beaulieu, Carlo Carandang, Alain Labelle, Pierre Lalonde, Ashok Malla, Heather Milliken, Claire O’Donovan, Ayal Schaffer, Jorge Soni, Valerie H Taylor & Richard Williams. (2013) Evidence review and clinical guidance for the use of ziprasidone in Canada. Annals of General Psychiatry 12:1, pages 1.
Crossref
Crossref
Leslie Citrome. (2012) Oral Antipsychotic Update: A Brief Review of New and Investigational Agents for the Treatment of Schizophrenia. CNS Spectrums 17:s1, pages 1-9.
Crossref
Crossref
Steven L. DubovskyAmelia N. Dubovsky. (2012) Maintenance Treatment of Bipolar Disorder with Ziprasidone in Adjunctive Use with Lithium or Valproate. Clinical Medicine Insights: Therapeutics 4, pages CMT.S7369.
Crossref
Crossref
Leslie Citrome, Xiangyi Meng, Marla Hochfeld & Stephen M Stahl. (2012)
Efficacy of iloperidone in the short-term treatment of schizophrenia: a
post hoc
analysis of pooled patient data from four phase III, placebo- and active-controlled trials
. Human Psychopharmacology: Clinical and Experimental 27:1, pages 24-32.
Crossref
Crossref
Catherine A. Harrington & Clayton English. (2012) Adverse Drug Events Related to Ziprasidone: A Meta‐analysis of Randomized, Placebo‐Controlled Trials. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 31:9, pages 840-849.
Crossref
Crossref
Lei Zhang, Jingjing Huang, Wenjuan Yu, Shen He, Yimin Yu, Fei Gu, Dan Tang, Hao Wang, Qingshan Zheng, YIfeng Shen, Jianping Zhang & Huafang Li. (2021) Head-to-Head Comparisons of Serum Prolactin Elevation Induced by 9 Second-Generation Antipsychotics In a Large Cohort of Patients With Schizophrenia: Analysis From a Real-World Study Database. SSRN Electronic Journal.
Crossref
Crossref